Coexpression cluster:C1750
From FANTOM5_SSTAR
Full id: C1750_Monocytederived_Fibroblast_Mesenchymal_Smooth_Macrophage_CD14_Pericytes
Phase1 CAGE Peaks
Hg19::chr15:72668281..72668373,- | p1@HEXA |
Hg19::chr17:42422629..42422636,+ | p3@GRN |
Hg19::chr17:42422637..42422655,+ | p2@GRN |
Hg19::chr20:44519948..44519986,+ | p1@CTSA |
Hg19::chr20:44519987..44519999,+ | p3@CTSA |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0004186 | carboxypeptidase C activity | 0.00430137713279296 |
GO:0005764 | lysosome | 0.00430137713279296 |
GO:0000323 | lytic vacuole | 0.00430137713279296 |
GO:0005773 | vacuole | 0.00430137713279296 |
GO:0004563 | beta-N-acetylhexosaminidase activity | 0.00620624403326304 |
GO:0006689 | ganglioside catabolic process | 0.00620624403326304 |
GO:0050884 | neuromuscular process controlling posture | 0.00620624403326304 |
GO:0046479 | glycosphingolipid catabolic process | 0.00678787958567052 |
GO:0019377 | glycolipid catabolic process | 0.00723976547420677 |
GO:0019915 | sequestering of lipid | 0.00723976547420677 |
GO:0001573 | ganglioside metabolic process | 0.00723976547420677 |
GO:0007628 | adult walking behavior | 0.00723976547420677 |
GO:0004185 | serine carboxypeptidase activity | 0.00918812158171093 |
GO:0007267 | cell-cell signaling | 0.00922311555031341 |
GO:0008344 | adult locomotory behavior | 0.0101338814539278 |
GO:0030149 | sphingolipid catabolic process | 0.0101788223163941 |
GO:0015929 | hexosaminidase activity | 0.0108558122730047 |
GO:0050885 | neuromuscular process controlling balance | 0.0108558122730047 |
GO:0006687 | glycosphingolipid metabolic process | 0.0108558122730047 |
GO:0007040 | lysosome organization and biogenesis | 0.0108558122730047 |
GO:0007033 | vacuole organization and biogenesis | 0.0113264700810796 |
GO:0050905 | neuromuscular process | 0.0113264700810796 |
GO:0046466 | membrane lipid catabolic process | 0.0113264700810796 |
GO:0042552 | myelination | 0.0117218610643795 |
GO:0030534 | adult behavior | 0.0117218610643795 |
GO:0006664 | glycolipid metabolic process | 0.0119745955732875 |
GO:0007272 | ensheathment of neurons | 0.0119745955732875 |
GO:0008366 | axon ensheathment | 0.0119745955732875 |
GO:0006672 | ceramide metabolic process | 0.0119745955732875 |
GO:0046519 | sphingoid metabolic process | 0.0126595217242665 |
GO:0001508 | regulation of action potential | 0.0139992529683599 |
GO:0044242 | cellular lipid catabolic process | 0.0159503329124385 |
GO:0030203 | glycosaminoglycan metabolic process | 0.0159503329124385 |
GO:0006022 | aminoglycan metabolic process | 0.0159503329124385 |
GO:0006665 | sphingolipid metabolic process | 0.0210614992510894 |
GO:0004180 | carboxypeptidase activity | 0.0219788420698607 |
GO:0046982 | protein heterodimerization activity | 0.0307300006956865 |
GO:0050954 | sensory perception of mechanical stimulus | 0.0366217204028624 |
GO:0007605 | sensory perception of sound | 0.0366217204028624 |
GO:0016042 | lipid catabolic process | 0.0394769015844559 |
GO:0007626 | locomotory behavior | 0.047697623954621 |
GO:0008238 | exopeptidase activity | 0.0477278536872717 |
GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds | 0.0477278536872717 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
somatic cell | 6.75e-15 | 591 |
monopoietic cell | 3.81e-13 | 63 |
monocyte | 3.81e-13 | 63 |
monoblast | 3.81e-13 | 63 |
promonocyte | 3.81e-13 | 63 |
animal cell | 1.23e-12 | 679 |
eukaryotic cell | 1.23e-12 | 679 |
macrophage dendritic cell progenitor | 5.32e-12 | 65 |
non-terminally differentiated cell | 6.18e-12 | 180 |
mesodermal cell | 8.09e-12 | 119 |
granulocyte monocyte progenitor cell | 2.39e-09 | 71 |
myeloid lineage restricted progenitor cell | 3.11e-09 | 70 |
fibroblast | 4.30e-09 | 75 |
multi fate stem cell | 1.01e-08 | 430 |
CD14-positive, CD16-negative classical monocyte | 2.06e-08 | 42 |
classical monocyte | 6.87e-08 | 45 |
somatic stem cell | 7.64e-08 | 436 |
myeloid leukocyte | 9.46e-08 | 76 |
lining cell | 1.17e-07 | 57 |
barrier cell | 1.17e-07 | 57 |
meso-epithelial cell | 6.60e-07 | 44 |
Ontology term | p-value | n |
---|---|---|
mesoderm | 5.06e-19 | 448 |
mesoderm-derived structure | 5.06e-19 | 448 |
presumptive mesoderm | 5.06e-19 | 448 |
lateral plate mesoderm | 3.04e-17 | 216 |
multi-cellular organism | 8.29e-14 | 659 |
musculoskeletal system | 1.66e-13 | 167 |
anatomical group | 1.01e-11 | 626 |
immune system | 1.11e-11 | 115 |
anatomical system | 1.15e-11 | 625 |
bone marrow | 3.10e-10 | 80 |
bone element | 1.41e-09 | 86 |
skeletal element | 4.03e-09 | 101 |
skeletal system | 4.03e-09 | 101 |
epithelial tube | 1.98e-08 | 118 |
organ | 3.36e-08 | 511 |
hemolymphoid system | 9.48e-08 | 112 |
splanchnic layer of lateral plate mesoderm | 3.11e-07 | 84 |
germ layer | 6.58e-07 | 604 |
embryonic tissue | 6.58e-07 | 604 |
presumptive structure | 6.58e-07 | 604 |
epiblast (generic) | 6.58e-07 | 604 |
embryonic structure | 7.45e-07 | 605 |
developing anatomical structure | 7.45e-07 | 605 |
circulatory system | 9.28e-07 | 113 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.